The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Omalizumab for asthma in adults and children
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2014
|
| DOI | 10.1002/14651858.cd003559.pub4 |
| Pubmed ID | |
| Authors |
Rebecca Normansell, Samantha Walker, Stephen J Milan, E. Haydn Walters, Parameswaran Nair |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 7% |
| United Kingdom | 2 | 7% |
| Argentina | 1 | 4% |
| Israel | 1 | 4% |
| Ireland | 1 | 4% |
| Colombia | 1 | 4% |
| Unknown | 20 | 71% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 68% |
| Practitioners (doctors, other healthcare professionals) | 6 | 21% |
| Scientists | 2 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 674 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Japan | 2 | <1% |
| Tunisia | 1 | <1% |
| South Africa | 1 | <1% |
| Mexico | 1 | <1% |
| Unknown | 667 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 86 | 13% |
| Student > Bachelor | 82 | 12% |
| Researcher | 72 | 11% |
| Student > Ph. D. Student | 64 | 9% |
| Other | 41 | 6% |
| Other | 141 | 21% |
| Unknown | 188 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 260 | 39% |
| Nursing and Health Professions | 39 | 6% |
| Agricultural and Biological Sciences | 26 | 4% |
| Biochemistry, Genetics and Molecular Biology | 24 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 4% |
| Other | 87 | 13% |
| Unknown | 214 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2024.
All research outputs
#1,129,353
of 26,565,554 outputs
Outputs from Cochrane database of systematic reviews
#2,120
of 13,244 outputs
Outputs of similar age
#11,723
of 324,349 outputs
Outputs of similar age from Cochrane database of systematic reviews
#43
of 245 outputs
Altmetric has tracked 26,565,554 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,244 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,349 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 245 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.